Rising Cases OF Diarrhea To Increase Demand In Global Antidiarrheal Drugs Market

Antidiarrheal drugs help in treating suddenly loose stools by reducing the gut metabolism and controlling bowel movements. It also helps in making the stool less watery. There are several factors causing diarrhea such as virus like hepatitis and rotavirus or bacteria like Shigella, E. coli, or parasites that cause giardiasis and causing amoebiasis. Usually, most of the diarrheal events can be controlled by changing the diet and do not require any specific medication or treatment. However, in case of severe diarrhea, it needs lab tests including stool samples and blood tests to analyze the root cause.

Discopodium Penninervum is a medicinal plant that possesses anti-diarrheal properties owing to its anti-microbial and anti-bacterial features. Thus, they are very helpful in the treatment of the illness. It contains phenols, tannins, flavanoids, and saponin with similar properties. Drugs such as atropine and loperamide are also used for the antidiarrheal treatment. The latter helps in treating diarrhea in infants and children.

As reported, Racecadotril, also known as acetorphan, is utilized for treating loose bowels and has been reported effective for acute diarrhea in kids and adults. It can control the symptoms in 1 or 2 days. For the record, bismuth subsalicylate is utilized in treating travelers’ diarrhea and is utilized for decreasing diarrheal episodes. Moreover, antidiarrheal ingredients like clonidine and lidamidine drugs are utilized for treating diabetic loose motions. Also, prostaglandin synthetase inhibitors are utilized for the treatment of inflammatory diarrhea and somatostatin is an antidiarrheal medicine for hormonally intervened loose motions.

Rising supportive government initiatives for building a strong medical services framework will make new development avenues for the global antidiarrheal drugs market in the future. Increasing awareness regarding antidiarrheal medications because of expansion in the instances of diarrhea will control the business patterns. Exponential demands for antidiarrheal medications in developing nations as well as underdeveloped ones will drive the business in coming years. Besides, antidiarrheal drugs are used for the treatment of loose bowels they reduce gut movement. Nevertheless, symptoms of the drugs like vomiting, bloating, constipation, nausea, dizziness are likely to restrict the market development.

The global antidiarrheal drugs market is broadly divided into application, type, and region. The application segment is bifurcated into children and adults. In terms of type, the global market is divided into prescription drugs and OTC drugs.

Geographically, North America is expected to lead the global antidiarrheal drugs market within the forecast period. The growth is attributed to increasing cases of diarrhea among people. In addition, acute diarrhea is one of the highly reported health issues in the US along with being the key death cause as well.

The leading players in the global antidiarrheal drugs market are Pfizer, Inc., tannins, Actelion, Glenmark Pharmaceuticals, GSK, and Perrigo. As per the report, on 1 March 2021, an already FDA-approved drug for treating diarrhea has proven to be effective in mitigating the chemotherapy resistance for one of the most difficult cancers. The report is published by Science Translational Medicine.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *